Mikael Björnstedt

About me
Publications
CV
Public outreach and news

About me

Mikael Björnstedt is Professor of Pathology at Karolinska Institutet since
2010. His research is about the cellular mechanisms behind selenium's
cytotoxic and cancer-preventive effects.

Articles

Article: CANCER RESEARCH. 2023;83(10):1628-1645

FPR2 Shapes an Immune-Excluded Pancreatic Tumor Microenvironment and Drives T-cell Exhaustion in a Sex-Dependent Manner

He F; Tay AHM; Calandigary A; Malki E; Suzuki S; Liu T; Wang Q; Fernandez-Moro C; Kaisso M; Olofsson-Sahl P; Melssen M; Sze SK; Bjornstedt M; Lohr MJ; Karlsson MCI; Heuchel R; Sarhan D
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;24(3):2485

Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses

Kamp JC; Kappe NN; Moro CF; Fuge J; Kuehnel MP; Wrenger S; Welte T; van Hoek B; Jonigk DD; Khedoe PPSJ; Strnad P; Bjornstedt M; Stolk J; Janciauskiene S; Nemeth A
Article: BIOMEDICINES. 2023;11(2):295

Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites

Breuer O; Brodin O; Razaghi A; Brodin D; Gammelgaard B; Bjoernstedt M
Article: ANTIOXIDANTS. 2023;12(1):167

Exploration of Patient-Derived Pancreatic Ductal Adenocarcinoma Ex Vivo Tissue for Treatment Response

Szekerczes T; Selvam AK; Moro CF; Elduayen SP; Dillner J; Bjornstedt M; Ghaderi M
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2022;56(1):166-173

Morphological changes without histological myocarditis in hearts of COVID-19 deceased patients

Razaghi A; Szakos A; Al-Shakarji R; Bjornstedt M; Szekely L
Article: DIAGNOSTICS. 2022;12(11):2789

Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers

Razaghi A; Szakos A; Alouda M; Bozoky B; Bjornstedt M; Szekely L
Article: JOURNAL OF MEDICAL IMAGING. 2022;9(3):031503

Can laboratory x-ray virtual histology provide intraoperative 3D tumor resection margin assessment?

Twengstrom W; Moro CF; Romell J; Larsson JC; Sparrelid E; Bjornstedt M; Hertz HM
Article: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 2022;662:25-62

Methods for accurate and reproducible studies of pharmacological effects of selenium in cancer.

Selvam AK; Szekerczés T; Björnstedt S; Razaghi A; Björnstedt M
Article: FRONTIERS IN ONCOLOGY. 2022;12:906134

Soluble PD-L1 Expression After Intravenous Treatment of Cancer Patients With Selenite in Phase I Clinical Trial

Razaghi A; Mansouri L; Brodin O; Bjoernstedt M; Lundahl J
Article: FRONTIERS IN ONCOLOGY. 2022;12:965182

Drug-induced tumor-specific cytotoxicity in a whole tissue ex vivo model of human pancreatic ductal adenocarcinoma

Moro CF; Selvam AK; Ghaderi M; Pimenoff VN; Gerling M; Bozoky B; Elduayen SP; Dillner J; Bjoernstedt M
Article: NEOPLASIA. 2021;23(10):1059-1068

Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy

Razaghi A; Brusselaers N; Bjornstedt M; Durand-Dubief M
Article: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021;110:433-435

Severe features during outbreak but low mortality observed imme diately b efore and after a March-May 2020 COVID-19 outbreak in Stockholm, Sweden

Pimenoff VN; Bjornstedt M; Dillner J
Article: ANTIOXIDANTS. 2021;10(7):1094

A Novel mRNA-Mediated and MicroRNA-Guided Approach to Specifically Eradicate Drug-Resistant Hepatocellular Carcinoma Cell Lines by Se-Methylselenocysteine

Selvam AK; Jawad R; Gramignoli R; Achour A; Salter H; Bjornstedt M
Article: CLINICAL INFECTIOUS DISEASES. 2021;72(11):e890-e892

Estimating Total Excess Mortality During a Coronavirus Disease 2019 Outbreak in Stockholm, Sweden

Pimenoff VN; Elfstrom M; Baussano I; Bjornstedt M; Dillner J
Article: HELIYON. 2021;7(6):e07254

Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha

Razaghi A; Zickler AM; Spallholz J; Kirsch G; Bjornstedt M
Article: HELIYON. 2021;7(5):e07134

Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death

Szekely L; Bozoky B; Bendek M; Ostad M; Lavignasse P; Haag L; Wu J; Jing X; Gupta S; Saccon E; Sonnerberg A; Cao Y; Bjornstedt M; Szakos A
Article: PATHOLOGY & ONCOLOGY RESEARCH. 2020;26(4):2669-2681

The Effect of Methylselenocysteine and Sodium Selenite Treatment on microRNA Expression in Liver Cancer Cell Lines

Lendvai G; Szekerczes T; Kontsek E; Selvam A; Szakos A; Schaff Z; Bjornstedt M; Kiss A
Article: PATHOLOGY & ONCOLOGY RESEARCH. 2020;26(4):2401-2407

Mid-Infrared Imaging Is Able to Characterize and Separate Cancer Cell Lines

Kontsek E; Pesti A; Bjornstedt M; Uveges T; Szabo E; Garay T; Gordon P; Gergely S; Kiss A
Article: SCIENTIFIC REPORTS. 2020;10(1):9070

Genome-wide transcriptome profiling of ex-vivo precision-cut slices from human pancreatic ductal adenocarcinoma

Ghaderi M; Moro CF; Elduayen SP; Hultin E; Verbeke CS; Bjornstedt M; Dillner J
Article: NUTRIENTS. 2020;12(4):E1067-1067

Selenoprotein P as Biomarker of Selenium Status in Clinical Trials with Therapeutic Dosages of Selenite

Brodin O; Hackler J; Misra S; Wendt S; Sun Q; Laaf E; Stoppe C; Bjornstedt M; Schomburg L
Article: ANTIOXIDANTS. 2020;9(2):E139-139

A Novel Assay Method to Determine the β-Elimination of Se-Methylselenocysteine to Monomethylselenol by Kynurenine Aminotransferase 1

Selvam AK; Bjornstedt M
Article: ANTIOXIDANTS. 2019;8(5):E130-130

The Cell Culture Medium Affects Growth, Phenotype Expression and the Response to Selenium Cytotoxicity in A549 and HepG2 Cells

Selenius LA; Lundgren MW; Jawad R; Danielsson O; Bjornstedt M
Article: SCIENTIFIC REPORTS. 2019;9(1):2133

Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma

Misra S; Moro CF; Del Chiaro M; Pouso S; Sebestyen A; Lohr M; Bjornstedt M; Verbeke CS
Article: FRONTIERS IN IMMUNOLOGY. 2018;9:1326

Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface Signatures

Wiklander OPB; Bostancioglu RB; Welsh JA; Zickler AM; Murke F; Corso G; Felldin U; Hagey DW; Evertsson B; Liang X-M; Gustafsson MO; Mohammad DK; Wiek C; Hanenberg H; Bremer M; Gupta D; Bjornstedt M; Giebel B; Nordin JZ; Jones JC; EL Andaloussi S; Goergens A
Article: WORLD JOURNAL OF HEPATOLOGY. 2017;9(34):1261-1269

Morphological alterations and redox changes associated with hepatic warm ischemia-reperfusion injury.

Jawad R; D'souza M; Selenius LA; Lundgren MW; Danielsson O; Nowak G; Björnstedt M; Isaksson B
Article: ONCOTARGET. 2016;7(46):74686-74700

Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells

Misra S; Selvam AK; Wallenberg M; Ambati A; Matolcsy A; Magalhaes I; Lauter G; Bjornstedt M
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2016;408(9):2293-2301

Quantification of low molecular weight selenium metabolites in human plasma after treatment with selenite in pharmacological doses by LC-ICP-MS

Flouda K; Dersch JM; Gabel-Jensen C; Sturup S; Misra S; Bjornstedt M; Gammelgaard B
Article: PLOS ONE. 2016;11(11):e0166067

Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification

Moro CF; Fernandez-Woodbridge A; D'souza MA; Zhang Q; Bozoky B; Kandaswamy SV; Catalano P; Heuchel R; Shtembari S; Del Chiaro M; Danielsson O; Bjornstedt M; Lohr JM; Isaksson B; Verbeke C; Bozoky B
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2016;70(1):91-96

Relatively high mortality risk in elderly Swedish subjects with low selenium status

Alehagen U; Johansson P; Bjornstedt M; Rosen A; Post C; Aaseth J
Article: NUTRIENTS. 2015;7(6):4978-4994

Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study

Brodin O; Eksborg S; Wallenberg M; Asker-Hagelberg C; Larsen EH; Mohlkert D; Lenneby-Helleday C; Jacobsson H; Linder S; Misra S; Bjornstedt M
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2014;18(4):671-684

Selenium induces a multi- targeted cell death process in addition to ROS formation

Wallenberg M; Misra S; Wasik AM; Marzano C; Bjornstedt M; Gandin V; Fernandes AP
Article: JOURNAL OF ALZHEIMERS DISEASE. 2014;39(4):787-797

Alteration of Thioredoxin and Glutaredoxin in the Progression of Alzheimer's Disease

Arodin L; Lamparter H; Karlsson H; Nennesmo I; Bjoernstedt M; Schroder J; Fernandes AP
Article: JOURNAL OF INHERITED METABOLIC DISEASE. 2013;36(6):1063-1071

High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria

Sardh E; Wahlin S; Bjornstedt M; Harper P; Andersson DEH
Article: DISEASES OF THE ESOPHAGUS. 2013;26(8):853-858

Nitric oxide and endothelin-1 release after one-lung ventilation during thoracoabdominal esophagectomy

Lund M; Ny L; Malmstrom RE; Lundberg JO; Ost A; Bjornstedt M; Lundell L; Tsai JA
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2013;167(5):1860-1866

Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens

Alehagen U; Johansson P; Bjornstedt M; Rosen A; Dahlstrom U
Article: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2012;16(7):1593-1605

Effects of redox modulation by inhibition of thioredoxin reductase on radiosensitivity and gene expression

Selenius M; Hedman M; Brodin D; Gandin V; Rigobello MP; Flygare J; Marzano C; Bindoli A; Brodin O; Bjornstedt M; Fernandes AP
Article: DIGESTIVE DISEASES AND SCIENCES. 2012;57(5):1163-1170

The Value of Thioredoxin Family Proteins and Proliferation Markers in Dysplastic and Malignant Gallbladders in Patients with Primary Sclerosing Cholangitis

Said K; Glaumann H; Bjornstedt M; Bergquist A
Article: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY. 2012;21(1):6-12

Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma.

Larsson P; Arvidsson D; Björnstedt M; Isaksson B; Jersenius U; Motarjemi H; Jacobsson H
Article: PLOS ONE. 2012;7(11):e50727

Methylselenol Formed by Spontaneous Methylation of Selenide Is a Superior Selenium Substrate to the Thioredoxin and Glutaredoxin Systems

Fernandes AP; Wallenberg M; Gandin V; Misra S; Tisato F; Marzano C; Rigobello MP; Kumar S; Bjornstedt M
Article: JOURNAL OF IMMUNOLOGY. 2011;187(7):3546-3554

Selenite Induces Posttranscriptional Blockade of HLA-E Expression and Sensitizes Tumor Cells to CD94/NKG2A-Positive NK Cells

Enqvist M; Nilsonne G; Hammarfjord O; Wallin RPA; Bjoerkstroem NK; Bjornstedt M; Hjerpe A; Ljunggren H-G; Dobra K; Malmberg K-J; Carlsten M
Article: JOURNAL OF SURGICAL RESEARCH. 2011;169(2):214-219

Continuous Assessment of Intrahepatic Metabolism by Microdialysis During and After Portal Triad Clamping

Isaksson B; D'souza MA; Jersenius U; Ungerstedt J; Lundell L; Permert J; Bjoernstedt M; Nowak G
Article: FREE RADICAL BIOLOGY AND MEDICINE. 2011;50(11):1620-1629

Interaction of selenite and tellurite with thiol-dependent redox enzymes: Kinetics and mitochondrial implications

Rigobello MP; Folda A; Citta A; Scutari G; Gandin V; Fernandes AP; Rundloef A-K; Marzano C; Bjoernstedt M; Bindoli A
Article: EPMA JOURNAL. 2010;1(3):389-395

Selenium in the prevention of human cancers.

Björnstedt M; Fernandes AP
Article: BIOCHEMICAL JOURNAL. 2010;429(1):85-93

Selenium compounds are substrates for glutaredoxins: a novel pathway for selenium metabolism and a potential mechanism for selenium-mediated cytotoxicity

Wallenberg M; Olm E; Hebert C; Bjornstedt M; Fernandes AP
Article: BIOCHEMICAL PHARMACOLOGY. 2010;79(2):90-101

Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase

Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Bjornstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Article: FREE RADICAL BIOLOGY AND MEDICINE. 2009;47(6):710-721

Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift

Rigobello MP; Gandin V; Folda A; Rundlof A-K; Fernandes AP; Bindoli A; Marzano C; Bjornstedt M
Article: CANCER LETTERS. 2009;282(1):116-123

Selenite is a potent cytotoxic agent for human primary AML cells

Olm E; Jonsson-Videsater K; Ribera-Cortada I; Fernandes AP; Eriksson LC; Lehmann S; Rundlof A-K; Paul C; Bjornstedt M
Article: HISTOPATHOLOGY. 2009;55(3):313-320

Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation

Fernandes AP; Capitanio A; Selenius M; Brodin O; Rundlof A-K; Bjornstedt M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(27):11400-11405

Extracellular thiol-assisted selenium uptake dependent on the x_c^- cystine transporter explains the cancer-specific cytotoxicity of selenite

Olm E; Fernandes AP; Hebert C; Rundlof A-K; Larsen EH; Danielsson O; Bjornstedt M
Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2009;28(1):92

Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure

Nilsonne G; Olm E; Szulkin A; Mundt F; Stein A; Kocic B; Rundlof A-K; Fernandes AP; Bjornstedt M; Dobra K
Article: FEBS JOURNAL. 2009;276(2):532-540

Effects of the antioxidant Pycnogenol^® on cellular redox systems in U1285 human lung carcinoma cells

Gandin V; Nystrom C; Rundlof A-K; Jonsson-Videsater K; Schonlau F; Horkko J; Bjornstedt M; Fernandes AP
Article: BIOCHEMICAL PHARMACOLOGY. 2008;75(11):2092-2099

Treatment of lung cancer cells with cytotoxic levels of sodium selenite:: Effects on the thioredoxin system

Selenius M; Fernandes AP; Brodin O; Bjornstedt M; Rundlof A-K
Article: GASTROENTEROLOGY. 2007;132(4):1504-1514

Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis

Karrar A; Broome U; Sodergren T; Jaksch M; Bergquist A; Bjornstedt M; Sumitran-Holgersson S
Article: DIFFERENTIATION. 2007;75(2):123-132

Quantification of alternative mRNA species and identification of thioredoxin reductase 1 isoforms in human tumor cells

Rundlof A-K; Fernandes AP; Selenius M; Babic M; Shariatgorji M; Nilsonne G; Ilag LL; Dobra K; Bjornstedt M
Article: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. 2007;20(1):17-24

Increased expression of specific thioredoxin family proteins;: A pilot immunohistochemical study on human hepatocellular carcinoma

Cunnea P; Fernandes AP; Capitanio A; Eken S; Spyrou G; Bjornstedt M
Article: JOURNAL OF HEPATOLOGY. 2007;46(1):174-179

Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis

Wahlin S; Aschan J; Bjornstedt M; Broome U; Harper P
Article: FREE RADICAL BIOLOGY AND MEDICINE. 2006;41(6):874-885

Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress

Nilsonne G; Sun X; Nystrom C; Rundlof A-K; Fernandes AP; Bjornstedt M; Dobra K
Article: TRANSPLANT INTERNATIONAL. 2005;18(8):992-1000

Adriamycin cytotoxicity may stimulate growth of hepatocellular tumours in an experimental model for adjuvant systemic chemotherapy in liver transplantation

Rissler P; Söderdahl G; Nordman T; Xia L; Torndal UB; Björnstedt M; Ericzon BG; Olsson JM; Eriksson LC
Article: BIOCHEMICAL PHARMACOLOGY. 2005;69(12):1765-1772

The role of thioredoxin reductase activity in selenium-induced cytotoxicity

Madeja Z; Sroka J; Nyström C; Björkhem-Bergman L; Nordman T; Damdimopoulos A; Nalvarte I; Eriksson LC; Spyrou G; Olsson JM; Björnstedt M
Article: BIOCHEMISTRY AND CELL BIOLOGY. 2005;83(2):196-211

Differential effects of selenite and selenate on human melanocytes, keratinocytes, and melanoma cells

Bandura L; Drukala J; Wolnicka-Glubisz A; Björnstedt M; Korohoda W
Article: CARCINOGENESIS. 2005;26(1):125-131

Selenium prevents tumor development in a rat model for chemical carcinogenesis

Björkhem-Bergman L; Torndal UB; Eken S; Nyström C; Capitanio A; Larsen EH; Björnstedt M; Eriksson LC
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(52):54510-54517

Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells -: Effect on cell growth and differentiation

Nalvarte I; Damdimopoulos AE; Nystöm C; Nordman T; Miranda-Vizuete A; Olsson JM; Eriksson L; Björnstedt M; Arnér ESJ; Spyrou G
Article: PEPTIDES. 2004;25(11):1849-1855

Mammalian thioredoxin reductase alters cytolytic activity of an antibacterial peptide

Björkhem-Bergman L; Jönsson-Videsäter K; Paul C; Björnstedt M; Andersson M
Article: BIOCHEMICAL PHARMACOLOGY. 2004;67(3):513-522

Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system

Jönsson-Videsäter K; Björkhem-Bergman L; Hossain A; Söderberg A; Eriksson LC; Paul C; Rosén A; Björnstedt M
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2003;278(4):2141-2146

The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone -: A novel mechanism for defense against oxidative stress

Xia L; Nordman T; Olsson JM; Damdimopoulos A; Björkhem-Bergman L; Nalvarte I; Eriksson LC; Arnér ESJ; Spyrou G; Björnstedt M
Article: BIOCHEMICAL PHARMACOLOGY. 2002;63(10):1875-1884

Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity -: Effects on thioredoxin reductase and glutathione reductase

Björkhem-Bergman L; Jönsson K; Eriksson LC; Olsson JM; Lehmann S; Paul C; Björnstedt M
Article: JOURNAL OF HEPATOLOGY. 2001;35(2):259-264

Increased levels of cytosolic thioredoxin reductase activity and mRNA in rat liver nodules

Björkhem L; Teclebrhan H; Kesen E; Olsson JM; Eriksson LC; Björnstedt M
Article: FEBS JOURNAL. 2001;268(5):1486-1490

Reduction of ubiquinone by lipoamide dehydrogenase -: An antioxidant regenerating pathway

Xia L; Björnstedt M; Nordman T; Eriksson LC; Olsson JM
Article: DIFFERENTIATION. 2000;66(4-5):181-188

Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells

Sun XJ; Dobra K; Björnstedt M; Hjerpe A
Article: FEBS LETTERS. 1999;448(1):190-192

Ubiquinone is reduced by lipoamide dehydrogenase and this reaction is potently stimulated by zinc

Olsson JM; Xia L; Eriksson LC; Björnstedt M
Article: FREE RADICAL BIOLOGY AND MEDICINE. 1998;24(7-8):1176-1186

Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery

Nakamura H; Vaage J; Valen G; Padilla CA; Björnstedt M; Holmgren A
Article: MOLECULAR IMMUNOLOGY. 1997;34(10):709-717

Human IgG is substrate for the thioredoxin system:: Differential cleavage pattern of interchain disulfide bridges in IgG subclasses

Magnusson CGM; Björnstedt M; Holmgren A
Article: CANCER RESEARCH. 1996;56(19):4407-4412

Selenite and selenate inhibit human lymphocyte growth via different mechanisms

Spyrou G; Bjornstedt M; Skog S; Holmgren A
Article: BIOCHEMISTRY. 1996;35(26):8511-8516

Selenite incubated with NADPH and mammalian thioredoxin reductase yields selenide, which inhibits lipoxygenase and changes the electron spin resonance spectrum of the active site iron

Bjornstedt M; Odlander B; Kuprin S; Claesson HE; Holmgren A
Article: FEBS LETTERS. 1995;368(1):59-63

AP-1 DNA-BINDING ACTIVITY IS INHIBITED BY SELENITE AND SELENODIGLUTATHIONE

SPYROU G; BJORNSTEDT M; KUMAR S; HOLMGREN A
Show more

All other publications

Review: FRONTIERS IN IMMUNOLOGY. 2023;14:1249330

Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy

Razaghi A; Durand-Dubief M; Brusselaers N; Bjornstedt M
Review: EUROPEAN JOURNAL OF CANCER. 2021;155:256-267

Selenium stimulates the antitumour immunity: Insights to future research

Razaghi A; Poorebrahim M; Sarhan D; Bjornstedt M
Review: NUTRIENTS. 2015;7(5):3536-3556

Redox-Active Selenium Compounds-From Toxicity and Cell Death to Cancer Treatment

Misra S; Boylan M; Selvam A; Spallholz JE; Bjornstedt M
Review: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2014;114(5):377-386

Selenium Cytotoxicity in Cancer

Wallenberg M; Misra S; Bjornstedt M
Review: ANTIOXIDANTS & REDOX SIGNALING. 2010;12(7):867-880

Selenium and the Selenoprotein Thioredoxin Reductase in the Prevention, Treatment and Diagnostics of Cancer

Selenius M; Rundlof A-K; Olm E; Fernandes AP; Bjornstedt M
Review: JOURNAL OF MOLECULAR BIOLOGY. 2007;370(2):331-348

Molecular and structural basis for redox regulation of β-actin

Lassing I; Schmitzberger F; Bjornstedt M; Holmgren A; Nordlund P; Schutt CE; Lindberg U
Meeting abstract: LUNG CANCER. 2006;54:S52

Targeting thioredoxin reductase -: a possible new treatment for malignant mesothelioma

Nilsonne G; Stein A; Rundloef A-K; Fernandes AP; Bjoernstedt M; Hjerpe A; Dobra K
Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 2004;378:131-138

Extramitochondrial reduction of ubiquinone by flavoenzymes

Björnstedt M; Nordman T; Olsson JM
Published conference paper: BIOFACTORS. 2003;18(1-4):45-50

Regeneration of the antioxidant ubiquinol by lipoamide dehydrogenase, thioredoxin reductase and glutathione reductase

Nordman T; Xia L; Björkhem-Bergman L; Damdimopoulos A; Nalvarte I; Arnér ESJ; Spyrou G; Eriksson LC; Björnstedt M; Olsson JM
Corrigendum: BIOCHEMICAL PHARMACOLOGY. 2002;64(1):159

Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity -: Effects on thioredoxin reductase and glutathione reductase (vol 63, pg 1875, 2002)

Björkhem-Bergman L; Jönsson K; Eriksson LC; Olsson JM; Lehmann S; Paul C; Björnstedt M
Published conference paper: CHEMICO-BIOLOGICAL INTERACTIONS. 2001;133(1-3):349-354

Alterations of glutathione levels and related enzyme activities in non-tumourous rat liver cells after long-term treatment with adriamycin and/or cyclosporine A

Carlson T; Björnstedt M; Rissler P; Bai L; Eriksson LC; Olsson JM
Review: BIOMEDICAL AND ENVIRONMENTAL SCIENCES. 1997;10(2-3):271-279

Selenium and the thioredoxin and glutaredoxin systems.

Björnstedt M; Kumar S; Björkhem L; Spyrou G; Holmgren A
Other: JOURNAL OF BIOLOGICAL CHEMISTRY. 1995;270(20):11761-11764

HUMAN THIOREDOXIN REDUCTASE DIRECTLY REDUCES LIPID HYDROPEROXIDES BY NADPH AND SELENOCYSTINE STRONGLY STIMULATES THE REACTION VIA CATALYTICALLY GENERATED SELENOLS

BJORNSTEDT M; HAMBERG M; KUMAR S; XUE J; HOLMGREN A
Other: JOURNAL OF BIOLOGICAL CHEMISTRY. 1995;270(8):3479-3482

1-CHLORO-2,4-DINITROBENZENE IS AN IRREVERSIBLE INHIBITOR OF HUMAN THIOREDOXIN REDUCTASE - LOSS OF THIOREDOXIN DISULFIDE REDUCTASE-ACTIVITY IS ACCOMPANIED BY A LARGE INCREASE IN NADPH OXIDASE ACTIVITY

ARNER ESJ; BJORNSTEDT M; HOLMGREN A
Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 1995;252:209-219

SELENITE AND SELENODIGLUTATHIONE - REACTIONS WITH THIOREDOXIN SYSTEMS

BJORNSTEDT M; KUMAR S; HOLMGREN A
Review: RECOMBINANT PROTEIN EXPRESSION: PROKARYOTIC HOSTS AND CELL-FREE SYSTEMS. 1995;252:199-208

THIOREDOXIN AND THIOREDOXIN REDUCTASE

HOLMGREN A; BJORNSTEDT M

Employments

Professor/Senior Physician, Department of Laboratory Medicine, Karolinska Institutet, 2010-

Degrees and Education

Docent, Karolinska Institutet, 2001
University Medical Degree, Karolinska Institutet, 1993

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI